Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07128589 · ClinicalTrials.gov registry record · NA
3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers
A NA study of Dental Restoration and Dental Veneers, sponsored by New York University.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT07128589 is a NA study of Dental Restoration and Dental Veneers that is actively recruiting participants, run by New York University. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07128589, a NA study of Dental Restoration and Dental Veneers, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical study aims to evaluate the clinical performance of 3M™ Filtek™ Supreme Flowable Composite in class IV and veneer indication. Follow-ups of 7 days, 6, 12, and 24 months will be conducted following an Fédération Dentaire Internationale (FDI) modified score (2023). A minimum of 50 Class IV and 25 veneers will be included in the evaluation. Research data and pictures will be provided for each patient pre-op and at 7 days (baseline, 6 months, 12 months and 24 months. Evaluation will be conducted by two calibrated evaluators different from the operator according to FDI clinical criteria.
Conditions Studied
Interventions
- DEVICE 3MTM FiltekTM Supreme Flowable Composite
Study Locations (1)
New York
- NYU College Of Dentistry - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-08-07 |
| Est. Completion | 2028-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07128589
The ClinicalTrials.gov registry entry for NCT07128589 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Dental Restoration appearing as the primary indexed condition, and to 1 intervention - of which 3MTM FiltekTM Supreme Flowable Composite is the first listed.
NCT07128589 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07128589 about?
NCT07128589 is a clinical study titled "3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers". This clinical study aims to evaluate the clinical performance of 3M™ Filtek™ Supreme Flowable Composite in class IV and veneer indication. Follow-ups of 7 days, 6, 12, and 24 months will be conducted following an Fédération Dentaire Internationale (FDI) modified score (2023). A minimum of 50 Class I...
What is the current status of trial NCT07128589?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-08-07. Estimated completion is 2028-09.
What conditions does trial NCT07128589 study?
This clinical trial studies the following conditions: Dental Restoration, Dental Veneers.
What interventions are being tested in trial NCT07128589?
The interventions under investigation include: 3MTM FiltekTM Supreme Flowable Composite (DEVICE).
Who is sponsoring clinical trial NCT07128589?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07128589 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.